|
Compared to Sequencing, MassARRAY provides a significant advantage for the detection of low frequent mutations – e.g. in admixed samples of tumor and healthy tissue
This has been demonstrated in several publications:
- Thomas, R K, et.al. (2007) Nature Genetics Mar;39(3):347-351
- Vivante, A et al. (2007) Leukemia; 21: 1318 - 21
|